At the NephCure Patient Summit, Montrez Lucas presented a session on how people with kidney disease can navigate insurance. Each week on DocWire News, editors bring you the latest news and research in hematology and oncology. Here are this ... Cancer surgeries at National Cancer Institute (NCI) centers are associated with higher insurer spending versus spending ... A study observed significant differences in healthcare resource utilization (HCRU) between patients with multiple ... A pay-for-performance (P4P) program for cancer drug reimbursement was found to increase use of evidence-based drugs ... Disruptions in health insurance coverage are common in the US and lead to poorer cancer outcomes, according to the ... A study evaluated the relationship between utilization management policy and uptake of hypofractionated radiotherapy in ... A study published in Cancer Epidemiology, Biomarkers & Prevention found that a breast cancer diagnosis in young ... According to the findings of a study published in the Journal of the National Comprehensive Cancer Network enrollment in ... A new study found that medical financial hardship and financial sacrifices pose a significant burden on cancer ... Short-term exposure to fine particulate matter with diameter less than 2.5 µm (PM2.5) is associated with increased ... A new analysis published in Circulation reveals that many patients with atherosclerotic cardiovascular disease (ASCVD) ... A new analysis evaluated the effects of the Affordable Care Act (ACA) on insurance coverage for patients with head and ... Generally, by the time a payers’ requirements for appeal submission have been met, the claim in question is past due ... Cancer survivors enrolled in high deductible health plans may delay or forgo cancer follow-up care, according to a study ... Earlier this year the California Assembly passed AB 290, a bill with the stated purpose of “preventing dialysis ... This week's edition looks at a new study of former NFL players and the risk for atrial fibrillation, new research ... Adverse cardiovascular outcomes were more prevalent among patients with rejected or abandoned PCSK9 inhibitor ... A new report in the Journal of General Internal Medicine indicates that despite some improvement in coverage with the ...